|
 

Synexus Currently Recruiting Patients to Assess New Treatment for Breathing Problems

Synexus, the world's largest multinational company dedicated to the successful recruitment and running of clinical studies, is currently recruiting patients for a study to assess a new treatment that could help provide relief for people suffering with Chronic Obstructive Pulmonary Disease (COPD).

 

Chronic Obstructive Pulmonary Disease (COPD) is a progressive respiratory disease that can be caused by smoking. It is one of the most common respiratory diseases in the UK. Around 835,000 people in the UK have been diagnosed with COPD but it is thought that there are about 2 million people living with the disease who have not been diagnosed [1]. People with COPD have breathing problems, including a shortness of breath, coughing and wheezing.

The study that Synexus is currently running is an assessment into a new treatment that may help ease the symptoms associated with COPD. The study involves taking an inhaler twice a day for approximately 6 months. The study may be suitable for those who are:

  • A current or ex smoker
  • Aged over 40 years old

Synexus is currently recruiting patients for this study at its Dedicated Clinical Research Centres across the UK. Those who would like to find out more or are interested in participating in this study should contact their nearest Synexus Clinical Research Centre and quote the relevant reference code:

  • Lancashire Clinical Research Centre - 01772 344620 (quote reference 5192)
  • Manchester Clinical Research Centre - 0161 608 7790 (quote reference 5193)
  • Merseyside Clinical Research Centre - 0151 5509951 (quote reference 5194)
  • Midlands Clinical Research Centre - 0121 414 0303 (quote reference 5195)
  • Scotland Clinical Research Centre - 0141 945 6850 (quote reference 5196)
  • Thames Valley Clinical Research Centre - 0118 3789923 (quote reference 5197)
  • Wales Clinical Research Centre - 02920 764455 (quote reference 5198)

There is no obligation for people to participate and if they do decide to take part, their GP will be kept fully informed of their involvement. Patients will be reimbursed for their time and out of pocket travelling expenses.

Synexus has many years experience in conducting a wide range of clinical studies. The purpose of a clinical research study is to answer important questions about a new medicine, for example: does it improve a persons health and which dose of the medicine works best?

Each year, thousands of patients take part in clinical studies at Synexus Dedicated Clinical Research Centres. There are many different studies running at each of the Centres throughout the year including potential treatments for conditions such as osteoporosis, smoking cessation, high-cholesterol, insomnia, vaccines, asthma and childhood eczema.

Not all studies are paid, but some do reimburse the patients for their time and all studies reimburse patients for out of pocket travelling expenses. Participating in a Synexus clinical study means patients receive increased medical attention and may benefit from medications that arent yet available to other sufferers of their condition, while making a positive contribution to the health of future generations.

For more information about Synexus and the other studies that it is currently conducting click here.

qr code
 
 
About The Operating Theatre Journal

The Operating Theatre Journal, OTJ, is published monthly and distributed to every hospital operating theatre department in the UK. The distribution includes both the National Health Service and the Private Sector.

More »
Follow & Share

Follow The Operating Theatre Journal on Facebook Follow The Operating Theatre Journal on Twitter Follow The Operating Theatre Journal on LinkedIn Follow The Operating Theatre Journal RSS Feed

Help & Support

Problems with, or comments about, this website may be emailed to:
webmaster@lawrand.com

Get in touch

Telephone: +44 (0)2921 680068
Skype: Lawrand Ltd
Email: admin@lawrand.com